Clinical Trials · NCT07218354

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

Phase
Phase 3
Recruitment status
Recruiting
Sponsor
VA Office of Research and Development
Enrollment
622
Start date
Jul 2026
Locations
19 sites, United States
Primary endpoint
Two-level reduction in the World Health Organization (WHO) risk drinking level assessed in the last 28 days of intervention
View Semaglutide compound reference